In 2023, we generated EUR 320.4 million in revenue, and our active custom projects pipeline included 204 projects at the end of the year. The structure of revenue and the active custom projects pipeline provide insights into our activities and the innovation efforts of our customers.

Helping patients across multiple health indications

Approx. revenue split by therapeutic areas (as per 31 December 2023)

Covid related

Servicing a diversified customer base

Approx. revenue split by customer type (as per 31 December 2023)

Large pharma
Other pharma & academia

Solutions for development and commercial products

Revenue by business area (as per 31 December 2023)

Custom Projects
Contract Manufacturing
Generetic & Cosmetics

“Start here – stay here”

Number of active custom projects (as per 31 December 2023)

Phase I
Phase II
Phase III